Preferred Name |
Tolbutamide |
|
Synonyms |
Tolbutamide TOLBUTAMIDE N-[(butylamino)carbonyl]-4-methylbenzenesulfonamide |
|
Definitions |
A short-acting, first-generation sulfonylurea with hypoglycemic activity. Compared to second-generation sulfonylureas, tolbutamide is more likely to cause adverse effects, such as jaundice. This agent is rapidly metabolized by CYPC29. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C66610 |
|
CAS_Registry |
64-77-7 |
|
CHEBI_ID |
CHEBI:27999 |
|
Chemical_Formula |
C12H18N2O3S |
|
code |
C66610 |
|
Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978 |
|
Contributing_Source |
CTRP FDA |
|
DEFINITION |
A short-acting, first-generation sulfonylurea with hypoglycemic activity. Compared to second-generation sulfonylureas, tolbutamide is more likely to cause adverse effects, such as jaundice. This agent is rapidly metabolized by CYPC29. |
|
Display_Name |
Tolbutamide |
|
FDA_UNII_Code |
982XCM1FOI |
|
FULL_SYN |
Tolbutamide TOLBUTAMIDE N-[(butylamino)carbonyl]-4-methylbenzenesulfonamide |
|
Has_Salt_Form | ||
label |
Tolbutamide |
|
Legacy Concept Name |
Tolbutamide |
|
NCI_Drug_Dictionary_ID |
684270 |
|
PDQ_Closed_Trial_Search_ID |
684270 |
|
PDQ_Open_Trial_Search_ID |
684270 |
|
Preferred_Name |
Tolbutamide |
|
prefixIRI |
Thesaurus:C66610 |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0040374 |
|
subClassOf |